skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 27  for All Library Resources

Results 1 2 next page
Refined by: List of all Versions New From Last Week remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

BMC cardiovascular disorders, 2024-05, Vol.24 (1), p.255-255 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2261 ;EISSN: 1471-2261 ;DOI: 10.1186/s12872-024-03924-w ;PMID: 38755595

Full text available

2
Ð 53-year-old female with stress-induced cardiomyopathy: Ð clinical case
Material Type:
Article
Add to My Research

Ð 53-year-old female with stress-induced cardiomyopathy: Ð clinical case

Bʺlgarska kardiologiâ, 2024-05 (1), p.107 [Peer Reviewed Journal]

COPYRIGHT 2024 Pensoft Publishers ;ISSN: 1310-7488 ;EISSN: 2683-1015 ;DOI: 10.3897/bgcardio.30.e117188

Full text available

3
Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy
Material Type:
Article
Add to My Research

Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy

Journal of the American Heart Association, 2024-05, Vol.13 (10), p.e033565-e033565 [Peer Reviewed Journal]

EISSN: 2047-9980 ;DOI: 10.1161/JAHA.123.033565 ;PMID: 38757491

Full text available

4
Cardiac L-type calcium channel regulation by Leucine-Rich Repeat-Containing Protein 10
Material Type:
Article
Add to My Research

Cardiac L-type calcium channel regulation by Leucine-Rich Repeat-Containing Protein 10

Channels (Austin, Tex.), 2024-12, Vol.18 (1), p.2355121-2355121 [Peer Reviewed Journal]

EISSN: 1933-6969 ;DOI: 10.1080/19336950.2024.2355121 ;PMID: 38762910

Full text available

5
Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast
Material Type:
Article
Add to My Research

Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast

Molecular biology reports, 2024-05, Vol.51 (1), p.661-661 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2024. The Author(s), under exclusive licence to Springer Nature B.V. ;ISSN: 0301-4851 ;EISSN: 1573-4978 ;DOI: 10.1007/s11033-024-09594-3 ;PMID: 38758505

Digital Resources/Online E-Resources

6
Obstructive hypertrophic cardiomyopathy: a review of new therapies
Material Type:
Article
Add to My Research

Obstructive hypertrophic cardiomyopathy: a review of new therapies

Future cardiology, 2023-10, Vol.19 (13), p.661

EISSN: 1744-8298 ;PMID: 37933625

Digital Resources/Online E-Resources

7
"successive Delivery Of An Investigational Medicinal Product For The Needs Of A Non-commercial Clinical Trial Entitled "sacubitril/valsartan In The Prevention Of Disease Progression In Patients With Arrhythmogenic Right Ventricular Cardiomyopathy, Multice
Material Type:
Newsletter Article
Add to My Research

"successive Delivery Of An Investigational Medicinal Product For The Needs Of A Non-commercial Clinical Trial Entitled "sacubitril/valsartan In The Prevention Of Disease Progression In Patients With Arrhythmogenic Right Ventricular Cardiomyopathy, Multice

MENA Report, 2024

2022 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info). ;EISSN: 2219-0112

Digital Resources/Online E-Resources

8
Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology
Material Type:
Newsletter Article
Add to My Research

Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology

NASDAQ OMX's News Release Distribution Channel, 2024

GlobeNewswire, Inc.

Digital Resources/Online E-Resources

9
UPDATE: Cytokinetics (CYTK: $59.53) price 5.6% below VWAP; -39c [0.7%]
Material Type:
Newsletter Article
Add to My Research

UPDATE: Cytokinetics (CYTK: $59.53) price 5.6% below VWAP; -39c [0.7%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 17, 2024

Digital Resources/Online E-Resources

10
UPDATE: Cytokinetics (CYTK: $59.92) price 5.5% below VWAP; reports Loss of $136m; -58c [1.0%]
Material Type:
Newsletter Article
Add to My Research

UPDATE: Cytokinetics (CYTK: $59.92) price 5.5% below VWAP; reports Loss of $136m; -58c [1.0%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 16, 2024

Digital Resources/Online E-Resources

11
Zolmax.com - American Consumer News: Tenaya Therapeutics (NASDAQ:TNYA) Price Target Cut to $16.00 by Analysts at Canaccord Genuity Group
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: Tenaya Therapeutics (NASDAQ:TNYA) Price Target Cut to $16.00 by Analysts at Canaccord Genuity Group

Newstex Global Business Blogs, 2024

Copyright Newstex May 20, 2024

Digital Resources/Online E-Resources

12
Lexicon Pharmaceuticals (LXRX: $1.85) sinks 4.6%; -9c [4.6%]
Material Type:
Newsletter Article
Add to My Research

Lexicon Pharmaceuticals (LXRX: $1.85) sinks 4.6%; -9c [4.6%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 17, 2024

Digital Resources/Online E-Resources

13
Applied Therapeutics (APLT: $4.25) price 5.7% below VWAP; reports Loss of $83.9m; -15c [3.4%]
Material Type:
Newsletter Article
Add to My Research

Applied Therapeutics (APLT: $4.25) price 5.7% below VWAP; reports Loss of $83.9m; -15c [3.4%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 17, 2024

Digital Resources/Online E-Resources

14
Mortalidad por Miocarditis Alcohólica en América Latina, 2000-2019
Material Type:
Article
Add to My Research

Mortalidad por Miocarditis Alcohólica en América Latina, 2000-2019

Revista Hispanoamericana de Ciencias de la Salud, 2023, Vol.9 (2), p.69-84

LICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI ;ISSN: 2215-4256

Digital Resources/Online E-Resources

15
Zolmax.com - American Consumer News: Analyzing Lexeo Therapeutics (NASDAQ:LXEO) and Repligen (NASDAQ:RGEN)
Material Type:
Web Resources
Add to My Research

Zolmax.com - American Consumer News: Analyzing Lexeo Therapeutics (NASDAQ:LXEO) and Repligen (NASDAQ:RGEN)

Newstex Global Business Blogs, 2024

Copyright Newstex May 20, 2024

Digital Resources/Online E-Resources

16
Lexeo Therapeutics (LXEO: $13.95) decreases on strong volume; -1c [0.1%] Vol Index 2.8 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

Lexeo Therapeutics (LXEO: $13.95) decreases on strong volume; -1c [0.1%] Vol Index 2.8 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 17, 2024

Digital Resources/Online E-Resources

17
UPDATE: BridgeBio Pharma (BBIO: $30.09) falls 3.4% from 14-day high; -95c [3.1%]
Material Type:
Newsletter Article
Add to My Research

UPDATE: BridgeBio Pharma (BBIO: $30.09) falls 3.4% from 14-day high; -95c [3.1%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 17, 2024

Digital Resources/Online E-Resources

18
UPDATE: BridgeBio Pharma (BBIO: $31.05) accelerates rise, up 7.3% in 2 days; +$2.10 [7.3%]
Material Type:
Newsletter Article
Add to My Research

UPDATE: BridgeBio Pharma (BBIO: $31.05) accelerates rise, up 7.3% in 2 days; +$2.10 [7.3%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 16, 2024

Digital Resources/Online E-Resources

19
Mayo Clinic Minute: Tips to prevent injuries while biking
Material Type:
Newsletter Article
Add to My Research

Mayo Clinic Minute: Tips to prevent injuries while biking

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd May 17, 2024

Digital Resources/Online E-Resources

20
Mayo Clinic Health System celebrates grand opening of Mankato hospital expansion and modernization
Material Type:
Newsletter Article
Add to My Research

Mayo Clinic Health System celebrates grand opening of Mankato hospital expansion and modernization

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd May 17, 2024

Digital Resources/Online E-Resources

Results 1 - 20 of 27  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To

Language 

  1. English  (26)
  2. Spanish  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait